X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (37460) 37460
Book Chapter (619) 619
Newspaper Article (99) 99
Newsletter (84) 84
Book / eBook (35) 35
Dissertation (32) 32
Magazine Article (16) 16
Conference Proceeding (7) 7
Publication (5) 5
Web Resource (3) 3
Reference (1) 1
Trade Publication Article (1) 1
Transcript (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
science & technology (30045) 30045
life sciences & biomedicine (27421) 27421
humans (27358) 27358
hepatocellular carcinoma (15333) 15333
male (12971) 12971
oncology (12933) 12933
female (12038) 12038
liver cancer (9691) 9691
middle aged (9448) 9448
carcinoma, hepatocellular - drug therapy (8747) 8747
animals (8434) 8434
cancer (8383) 8383
liver neoplasms - drug therapy (8203) 8203
carcinoma, hepatocellular - pathology (8164) 8164
liver neoplasms - pathology (8125) 8125
aged (7583) 7583
cell line, tumor (7493) 7493
hepatoma (6308) 6308
apoptosis (6281) 6281
adult (5897) 5897
tumors (5680) 5680
mice (5211) 5211
gastroenterology & hepatology (5208) 5208
metastasis (4694) 4694
care and treatment (4631) 4631
prognosis (4610) 4610
gene expression (4521) 4521
proteins (4513) 4513
carcinoma, hepatocellular - metabolism (4373) 4373
analysis (4131) 4131
liver neoplasms - metabolism (4104) 4104
treatment outcome (3918) 3918
chemotherapy (3877) 3877
health aspects (3851) 3851
cancer therapies (3789) 3789
research (3748) 3748
medical prognosis (3739) 3739
liver (3568) 3568
cell biology (3494) 3494
carcinoma, hepatocellular - therapy (3448) 3448
liver neoplasms - therapy (3383) 3383
kinases (3356) 3356
carcinoma, hepatocellular - genetics (3233) 3233
digestive system diseases (3222) 3222
cell proliferation (3201) 3201
apoptosis - drug effects (3172) 3172
development and progression (3103) 3103
liver neoplasms - genetics (3098) 3098
patients (2986) 2986
medicine (2883) 2883
cell proliferation - drug effects (2874) 2874
surgery (2792) 2792
genetic aspects (2766) 2766
signal transduction (2766) 2766
antineoplastic agents - pharmacology (2744) 2744
research article (2738) 2738
cell cycle (2733) 2733
risk factors (2667) 2667
antineoplastic agents - therapeutic use (2658) 2658
pharmacology & pharmacy (2623) 2623
science & technology - other topics (2583) 2583
biochemistry & molecular biology (2533) 2533
hepatitis (2518) 2518
aged, 80 and over (2503) 2503
gene expression regulation, neoplastic (2492) 2492
cell growth (2489) 2489
studies (2457) 2457
medicine & public health (2450) 2450
mice, nude (2321) 2321
multidisciplinary sciences (2316) 2316
retrospective studies (2278) 2278
metastases (2273) 2273
carcinoma, hepatocellular - mortality (2246) 2246
medicine, research & experimental (2245) 2245
research & experimental medicine (2243) 2243
liver neoplasms - mortality (2238) 2238
hep g2 cells (2186) 2186
immunohistochemistry (2117) 2117
lung cancer (2020) 2020
biomarkers (1942) 1942
drug therapy (1923) 1923
liver diseases (1917) 1917
science (1917) 1917
liver neoplasms - surgery (1896) 1896
carcinoma, hepatocellular - surgery (1889) 1889
xenograft model antitumor assays (1835) 1835
neoplasm staging (1819) 1819
carcinoma (1799) 1799
medical research (1786) 1786
survival (1740) 1740
survival analysis (1699) 1699
survival rate (1672) 1672
cirrhosis (1655) 1655
liver cirrhosis (1654) 1654
squamous cell carcinoma (1654) 1654
mice, inbred balb c (1645) 1645
niacinamide - analogs & derivatives (1640) 1640
colorectal cancer (1637) 1637
disease progression (1625) 1625
abridged index medicus (1615) 1615
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Gerstein Science - Stacks (9) 9
Sunnybrook Health Sciences Centre - Sunnybrook Stacks (5) 5
Online Resources - Online (4) 4
Collection Dvlpm't (Acquisitions) - Closed Orders (2) 2
Collection Dvlpm't (Acquisitions) - Vendor file (2) 2
UofT at Mississauga - Stacks (1) 1
Women's College Hospital - Stacks (1) 1
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (37326) 37326
Japanese (737) 737
Chinese (334) 334
German (163) 163
French (155) 155
Korean (82) 82
Russian (64) 64
Spanish (49) 49
Italian (34) 34
Portuguese (34) 34
Hungarian (25) 25
Polish (17) 17
Danish (9) 9
Czech (7) 7
Dutch (5) 5
Norwegian (5) 5
Arabic (4) 4
Croatian (3) 3
Finnish (3) 3
Swedish (3) 3
Bulgarian (2) 2
Romanian (2) 2
Turkish (2) 2
Icelandic (1) 1
Lithuanian (1) 1
Persian (1) 1
Slovak (1) 1
Ukrainian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


The Lancet (British edition), ISSN 0140-6736, 06/2017, Volume 389, Issue 10088, pp. 2492 - 2502
Summary Background For patients with advanced hepatocellular carcinoma, sorafenib is the only approved drug worldwide, and outcomes remain poor... 
Internal Medicine | Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Drug Administration Schedule | Humans | Antibodies, Monoclonal - adverse effects | Liver Neoplasms - drug therapy | Male | Response Evaluation Criteria in Solid Tumors | Treatment Outcome | Antineoplastic Agents - administration & dosage | Tumor Burden | Dose-Response Relationship, Drug | B7-H1 Antigen - metabolism | Carcinoma, Hepatocellular - drug therapy | Time Factors | Antibodies, Monoclonal - administration & dosage | Antineoplastic Agents - adverse effects | Nivolumab | Carcinoma, Hepatocellular - pathology | Biomarkers, Tumor - metabolism | Female | Liver Neoplasms - pathology | Aged | Virus diseases | Medical colleges | Care and treatment | Cell death | College teachers | Hepatoma | Comparative analysis | Drug approval | Therapy | Pemphigoid | Intravenous administration | Inhibitor drugs | PD-1 protein | Funding | Liver | Clinical trials | Hepatocellular carcinoma | Lymphocytes T | Infections | Metastasis | Dosage | Cancer therapies | B7 antigen | Acceptability | Incidence | Hepatitis | Liver cancer | Pathways | Quality | Immunotherapy | Safety management | Safety | Expansion | Drug dosages | Liver diseases | Effectiveness | Mortality | Group dynamics | Patients | Hospitals | Inhibitors | Immune checkpoint | Adults | Solid tumors | Hepatitis C virus | Hepatitis C | Tumors | Apoptosis | Index Medicus | Abridged Index Medicus
Journal Article
JAMA : the journal of the American Medical Association, ISSN 0098-7484, 07/2014, Volume 312, Issue 1, pp. 57 - 67
Journal Article
Acta biomaterialia, ISSN 1742-7061, 08/2017, Volume 58, pp. 168 - 180
Journal Article
The lancet oncology, ISSN 1470-2045, 07/2015, Volume 16, Issue 7, pp. 859 - 870
Journal Article
European journal of cancer (1990), ISSN 0959-8049, 11/2013, Volume 49, Issue 16, pp. 3412 - 3419
Abstract Purpose We assessed the safety of the multikinase inhibitor regorafenib in patients with hepatocellular carcinoma (HCC... 
Hematology, Oncology and Palliative Medicine | Second line | Regorafenib | Hepatocellular carcinoma | Tolerability | Safety | Receptor kinase inhibition | Safety Second line | Life Sciences & Biomedicine | Oncology | Science & Technology | Carcinoma, Hepatocellular - mortality | Humans | Middle Aged | Pyridines - pharmacokinetics | Male | Antineoplastic Agents - therapeutic use | Antineoplastic Agents - administration & dosage | Protein Kinase Inhibitors - adverse effects | Liver Neoplasms - mortality | Pyridines - adverse effects | Carcinoma, Hepatocellular - drug therapy | Time Factors | Antineoplastic Agents - adverse effects | Phenylurea Compounds - adverse effects | Adult | Female | Liver Neoplasms - pathology | Antineoplastic Agents - pharmacokinetics | Phenylurea Compounds - pharmacokinetics | Liver Neoplasms - enzymology | Pyridines - therapeutic use | Protein Kinase Inhibitors - pharmacokinetics | Pyridines - administration & dosage | Drug Administration Schedule | Europe | Kaplan-Meier Estimate | Liver Neoplasms - drug therapy | Phenylurea Compounds - therapeutic use | Treatment Outcome | Carcinoma, Hepatocellular - enzymology | Disease Progression | Protein Kinase Inhibitors - administration & dosage | Phenylurea Compounds - administration & dosage | Asia | Protein Kinase Inhibitors - therapeutic use | Carcinoma, Hepatocellular - pathology | Aged | Neoplasm Staging | Care and treatment | Safety and security measures | Hepatoma | Index Medicus
Journal Article
The New England journal of medicine, ISSN 1533-4406, 07/2008, Volume 359, Issue 4, pp. 378 - 390
Journal Article